Orijinal Araştırma


DOI :10.26650/eor.20200087   IUP :10.26650/eor.20200087    Tam Metin (PDF)

Saliva profiles in children with congenital heart disease

Mine KoruyucuŞule BatuMerve BayramFatma Ezel UsluYegane GüvenFigen Seymen

Purpose The low salivary pH and buffering capacity are caused by using heart failure medications. For this reason oral health should be supported in cardiac patients, it is necessary that they attend dental clinics for regular follow up. The aim of this study is to evaluate the relationship between the salivary oxidative stress markers and salivary pH, salivary buffering capacity, salivary flow rate and dental caries of children with congenital heart disease (CHD). Material and Methods This cross sectional study was carried out with 42 CHD and 42 healthy children. The participants’ gender, age, general health and medications, and caries scores (dfs/ DMFS) were written down, then their unstimulated saliva samples were collected. These specimens were evaluated in terms of the salivary secretion rate, salivary buffering capacity, pH, protein levels, superoxide dismutase (SOD), ferric reducing antioxidant power (FRAP), the thiobarbituric acid reactive substances (TBARS), protein carbonyl, protein thiols, total sialic acid. Results Both groups showed caries at similar levels. The salivary pH and buffering capacity were significantly less in the children with CHD than in the controls. The levels of TBARS and protein carbonyl were significantly higher in the children with CHD than in the controls. There was not any significant difference relating to the mean salivary secretion rate, protein levels, SOD, FRAP, protein thiols and total sialic acid. Conclusion The elevated TBARS and protein carbonyl levels in the patients with CHD were observed as an indicator of the free radical damage leading to oxidative stress. 


PDF Görünüm

Referanslar

  • 1. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900. [CrossRef] google scholar
  • 2. Cameron AC, Widmer RP. Handbook of Pediatric Dentistry 4th Ed.Mosby;. 2013, p.490-4. google scholar
  • 3. Rosén L, Rydberg A, Sjöström I, Stecksén-Blicks C. Saliva profiles in children using heart failure medication: a pilot study. Eur Arch Paediatr Dent 2010;11:187-91. [CrossRef] google scholar
  • 4. Koerdt S, Hartz J, Hollatz S, Frohwitter G, Kesting MR, Ewert P, et al. Dental prevention and disease awareness in children with congenital heart disease. Clin Oral Investig 2018;22(3):1487-93. [CrossRef] google scholar
  • 5. Aizenbud D, Peri-Front Y, Nagler RM. Salivary analysis and antioxidants in cleft lip and palate children. Arch Oral Biol 2008;53:517-22. [CrossRef] google scholar
  • 6. Foley JD, Sneed JD, Steinhubl SR, Kolasa J, Ebersole JL, Lin Y, et al. Oral fluids that detect cardiovascular disease biomarkers. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:207-14. [CrossRef] google scholar
  • 7. Dekker RL, Lennie TA, Moser DK, Miller CS, Ebersole JL, Chung ML, et al. Salivary Biomarkers, Oral Inflammation, and Functional Status in Patients With Heart Failure. Biol Res Nurs 2017;19:15361. [CrossRef] google scholar
  • 8. Hamilton C, Miller WH, Al-Benna S, Brosnan MJ, Drummond RD, McBride MW, et al. Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond) 2004;106:219-34. [CrossRef] google scholar
  • 9. Jain AK, Mehra NK, Swarnakar NK. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Curr Pharm Des 2015;21:4441-55. [CrossRef] google scholar
  • 10. Tóthová L, Kamodyová N, Červenka T, Celec P. Salivary markers of oxidative stress in oral diseases. Front Cell Infect Microbiol 2015;20:-73. [CrossRef] google scholar
  • 11. Tulunoglu Ö, Demirtas S, Tulunoglu I. Total antioxidant levels of saliva in children related to caries, age, and gender. Int J Paediatr Dent 2006;16:186-91. [CrossRef] google scholar
  • 12. Ericsson Y. Clinical investigations of the salivary buffering action. Acta Odontol Scand 1959;17:131-65. [CrossRef] google scholar
  • 13. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85. [CrossRef] 14. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500. google scholar
  • 15. Benzie IFF, Strain JJ. Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299:15-27. [CrossRef] google scholar
  • 16. Higueras V, Raya Á, Rodrigo J, Serra MÁ, Romá J, Romero FJ. Interferon decreases serum lipid peroxidation products of hepatitis C patients. Free Radic Biol Med 1994;16:131-3. [CrossRef] google scholar
  • 17. Reznick AZ, Shehadeh N, Shafir Y, Nagler RM. Free radicals related effects and antioxidants in saliva and serum of adolescents with Type 1 diabetes mellitus. Arch Oral Biol 2006;51:640-8. [CrossRef] google scholar
  • 18. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7. [CrossRef] google scholar
  • 19. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205. [CrossRef] google scholar
  • 20. Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J 1961;81:384-92. [CrossRef] google scholar
  • 21. Skoza L, Mohos S. Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation. Biochem J 1976;159:457-62. [CrossRef] google scholar
  • 22. Tram TH, Brand Miller JC, McNeil Y, McVeagh P. Sialic acid content of infant saliva: Comparison of breast fed with formula fed infants. Arch Dis Child 1997;77:315-8. [CrossRef] google scholar
  • 23. Dasanayake AP, Roseman JM, Caufield PW, Butts JT. Distribution and determinants of mutans streptococci among AfricanAmerican children and association with selected variables. Pediatr Dent 1995;17:192-8. google scholar
  • 24. Grahn K, Wikström S, Nyman L, Rydberg A, Stecksén-Blicks C. Attitudes about dental care among parents whose children suffer from severe congenital heart disease: a case-control study. Int J Paediatr Dent 2006;16:231-8. [CrossRef] google scholar
  • 25. Nunn JH, Ng SKF, Sharkey I, Coulthard M. The dental implications of chronic use of acidic medicines in medically compromised children. Pharm World Sci 2001;23:118-9. [CrossRef] google scholar
  • 26. Ahmed AF, El-Maraghy NN, Abdel Ghaney RH, Elshazly SM. Therapeutic effect of captopril, pentoxifylline, and cordyceps sinensis in pre-hepatic portal hypertensive rats. Saudi J Gastroenterol 2012;18:182-7. [CrossRef] google scholar
  • 27. Sheng R, Gu ZL, Xie ML. Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophy. Int J Cardiol 2013;162:199-209. [CrossRef] google scholar
  • 28. Tsuber V, Kadamov Y, Tarasenko L. Activation of antioxidant defenses in whole saliva by psychosocial stress is more manifested in young women than in young men. PLoS One 2014; 19;9(12):e115048. [CrossRef] google scholar
  • 29. Hegde AM, Kavita R, Sushma KS, Suchetha S. Salivary sialic acid levels and dental health in children with congenital heart disease. J Clin Pediatr Dent 2012;36:293-6. [CrossRef] google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Koruyucu, M., Batu, Ş., Bayram, M., Uslu, F.E., Güven, Y., & Seymen, F. (2020). Saliva profiles in children with congenital heart disease. European Oral Research, 54(1), 48-54. https://doi.org/10.26650/eor.20200087


AMA

Koruyucu M, Batu Ş, Bayram M, Uslu F E, Güven Y, Seymen F. Saliva profiles in children with congenital heart disease. European Oral Research. 2020;54(1):48-54. https://doi.org/10.26650/eor.20200087


ABNT

Koruyucu, M.; Batu, Ş.; Bayram, M.; Uslu, F.E.; Güven, Y.; Seymen, F. Saliva profiles in children with congenital heart disease. European Oral Research, [Publisher Location], v. 54, n. 1, p. 48-54, 2020.


Chicago: Author-Date Style

Koruyucu, Mine, and Şule Batu and Merve Bayram and Fatma Ezel Uslu and Yegane Güven and Figen Seymen. 2020. “Saliva profiles in children with congenital heart disease.” European Oral Research 54, no. 1: 48-54. https://doi.org/10.26650/eor.20200087


Chicago: Humanities Style

Koruyucu, Mine, and Şule Batu and Merve Bayram and Fatma Ezel Uslu and Yegane Güven and Figen Seymen. Saliva profiles in children with congenital heart disease.” European Oral Research 54, no. 1 (Nov. 2024): 48-54. https://doi.org/10.26650/eor.20200087


Harvard: Australian Style

Koruyucu, M & Batu, Ş & Bayram, M & Uslu, FE & Güven, Y & Seymen, F 2020, 'Saliva profiles in children with congenital heart disease', European Oral Research, vol. 54, no. 1, pp. 48-54, viewed 25 Nov. 2024, https://doi.org/10.26650/eor.20200087


Harvard: Author-Date Style

Koruyucu, M. and Batu, Ş. and Bayram, M. and Uslu, F.E. and Güven, Y. and Seymen, F. (2020) ‘Saliva profiles in children with congenital heart disease’, European Oral Research, 54(1), pp. 48-54. https://doi.org/10.26650/eor.20200087 (25 Nov. 2024).


MLA

Koruyucu, Mine, and Şule Batu and Merve Bayram and Fatma Ezel Uslu and Yegane Güven and Figen Seymen. Saliva profiles in children with congenital heart disease.” European Oral Research, vol. 54, no. 1, 2020, pp. 48-54. [Database Container], https://doi.org/10.26650/eor.20200087


Vancouver

Koruyucu M, Batu Ş, Bayram M, Uslu FE, Güven Y, Seymen F. Saliva profiles in children with congenital heart disease. European Oral Research [Internet]. 25 Nov. 2024 [cited 25 Nov. 2024];54(1):48-54. Available from: https://doi.org/10.26650/eor.20200087 doi: 10.26650/eor.20200087


ISNAD

Koruyucu, Mine - Batu, Şule - Bayram, Merve - Uslu, FatmaEzel - Güven, Yegane - Seymen, Figen. Saliva profiles in children with congenital heart disease”. European Oral Research 54/1 (Nov. 2024): 48-54. https://doi.org/10.26650/eor.20200087



ZAMAN ÇİZELGESİ


Gönderim11.12.2018
Kabul13.02.2019
Çevrimiçi Yayınlanma23.01.2020

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.